CLINICAL RESEARCH: ERECTILE DYSFUNCTION AND CARDIAC DISEASE
Erectile Dysfunction Predicts Coronary Heart Disease in Type 2 Diabetes
Ronald Ching-Wan Ma, MA*,
Wing-Yee So, MBChB*,
Xilin Yang, PhD*,
Linda Wai-Ling Yu, MBChB*,
Alice Pik-Shan Kong, MBChB*, ,
Gary Tin-Choi Ko, MD ,
Chun-Chung Chow, MBBS*,
Clive Stewart Cockram, MD*,
Juliana Chung-Ngor Chan, MD*, and
Peter Chun-Yip Tong, PhD*, ,*
* Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
Manuscript received October 2, 2007;
revised manuscript received January 30, 2008,
accepted February 5, 2008.
* Reprint requests and correspondence: Dr. Peter C. Y. Tong, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, N.T., Hong Kong SAR, China. (Email: ptong{at}cuhk.edu.hk).
Objectives: We examined the predictive power of erectile dysfunction (ED) on coronary heart disease (CHD) events in Chinese men with type 2 diabetes.
Background: Subjects with diabetes are prone to develop cardiovascular complications. Erectile dysfunction is strongly associated with CHD in cross-sectional studies, but prospective data are lacking.
Methods: A consecutive cohort of men with no clinical evidence of cardiovascular disease underwent comprehensive assessments for diabetic complications. Erectile dysfunction was defined according to the definition of the National Institutes of Health Consensus Conference 1992. Coronary heart disease events were censored with centralized territory-wide hospital databases in 2005.
Results: Of 2,306 subjects (age: 54.2 ± 12.7 years; follow-up: 4.0 [range 1.7 to 7.1] years), 26.7% had ED at baseline. The incidence of CHD events was higher in men with ED than those without (19.7/1,000 person-years, 95% confidence interval [CI] 14.3 to 25.2 person-years vs. 9.5/1,000 person-years, 95% CI 7.4 to 11.7 person-years). Men who developed CHD events were older; had a higher frequency of ED and microvascular complications; had longer duration of diabetes; and had higher blood pressure, total cholesterol, low-density lipoprotein cholesterol, and urinary albumin/creatinine ratio but lower high-density lipoprotein cholesterol and estimated glomerular filtration rate than those without CHD events. Erectile dysfunction remained an independent predictor for CHD events (hazard ratio 1.58, 95% CI 1.08 to 2.30, p = 0.018) after adjustment for other covariates along with age, duration of disease, and use of antihypertensive agents and albuminuria.
Conclusions: In type 2 diabetic men without clinically overt cardiovascular disease, the presence of ED predicts a new onset of CHD events. Symptoms of ED should be independently sought to identify high-risk subjects for comprehensive cardiovascular assessments.
|
Abbreviations and Acronyms
| | ACEI = angiotensin-converting enzyme inhibitor | | ACR = albumin/creatinine ratio | | ARB = angiotensin receptor blocker | | CHD = coronary heart disease | | CI = confidence interval | | DBP = diastolic blood pressure | | ED = erectile dysfunction | | eGFR = estimated glomerular filtration rate | | IIEF = International Index of Erectile Function | | PAD = peripheral arterial disease | | SBP = systolic blood pressure |
|
Related Articles
-
Erectile Dysfunction: The New Harbinger for Major Adverse Cardiac Events in the Diabetic Patient
- Robert A. Kloner
J. Am. Coll. Cardiol. 2008 51: 2051-2052.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A23-A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
G. I Hackett
Review: Androgens, erectile dysfunction and cardiovascular risk in type 2 diabetes
The British Journal of Diabetes & Vascular Disease,
September 1, 2009;
9(5):
214 - 217.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dweck, I. W Campbell, D. Miller, and C M. Francis
Clinical aspects of silent myocardial ischaemia: with particular reference to diabetes mellitus
The British Journal of Diabetes & Vascular Disease,
May 1, 2009;
9(3):
110 - 116.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Miner
Erectile Dysfunction and the "Window of Curability": A Harbinger of Cardiovascular Events
Mayo Clin. Proc.,
February 1, 2009;
84(2):
102 - 104.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nehra
Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions
Mayo Clin. Proc.,
February 1, 2009;
84(2):
139 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008.
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
373 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. I Hackett
Erectile dysfunction predicts cardiovascular risk in men
BMJ,
October 21, 2008;
337(oct21_2):
a2166 - a2166.
[Full Text]
|
 |
|

|
 |

|
 |
 
I. W Campbell
Erectile dysfunction in diabetes mellitus: a risk factor for cardiovascular disease
The British Journal of Diabetes & Vascular Disease,
September 1, 2008;
8(5):
212 - 213.
[PDF]
|
 |
|

|
 |

|
 |
 
Erectile Dysfunction: A New Risk Factor for Heart Disease
Journal Watch Cardiology,
June 25, 2008;
2008(625):
4 - 4.
[Full Text]
|
 |
|

|
 |

|
 |
 
R. A. Kloner
Erectile Dysfunction: The New Harbinger for Major Adverse Cardiac Events in the Diabetic Patient
J. Am. Coll. Cardiol.,
May 27, 2008;
51(21):
2051 - 2052.
[Full Text]
[PDF]
|
 |
|
|